Skip to main content
. 2020 Mar 17;38(19):2140–2150. doi: 10.1200/JCO.19.02654

TABLE 2.

Incidence of Treatment-Emergent Adverse Events That Occurred in More Than 10% of Patients in Either Phase

graphic file with name JCO.19.02654t2.jpg